内容标题18

  • <tr id='InO1u7'><strong id='InO1u7'></strong><small id='InO1u7'></small><button id='InO1u7'></button><li id='InO1u7'><noscript id='InO1u7'><big id='InO1u7'></big><dt id='InO1u7'></dt></noscript></li></tr><ol id='InO1u7'><option id='InO1u7'><table id='InO1u7'><blockquote id='InO1u7'><tbody id='InO1u7'></tbody></blockquote></table></option></ol><u id='InO1u7'></u><kbd id='InO1u7'><kbd id='InO1u7'></kbd></kbd>

    <code id='InO1u7'><strong id='InO1u7'></strong></code>

    <fieldset id='InO1u7'></fieldset>
          <span id='InO1u7'></span>

              <ins id='InO1u7'></ins>
              <acronym id='InO1u7'><em id='InO1u7'></em><td id='InO1u7'><div id='InO1u7'></div></td></acronym><address id='InO1u7'><big id='InO1u7'><big id='InO1u7'></big><legend id='InO1u7'></legend></big></address>

              <i id='InO1u7'><div id='InO1u7'><ins id='InO1u7'></ins></div></i>
              <i id='InO1u7'></i>
            1. <dl id='InO1u7'></dl>
              1. <blockquote id='InO1u7'><q id='InO1u7'><noscript id='InO1u7'></noscript><dt id='InO1u7'></dt></q></blockquote><noframes id='InO1u7'><i id='InO1u7'></i>
                   首页 >> 新闻动态 >> 学术活动

                学术活动

                10月25日澳门皇都游戏赌场院学术讲座预告

                发表日期:2019-10-25来源:放大 缩小

                  题目:Using stem cell technology and gene engineering approach to treat autoimmune disease and cancer

                  主讲人:Laijun Lai, MD(University of Connecticut Stem Cell Institute and Department of Allied Health Sciences)

                  时间:2019年10月25日 15:30-17:00 

                  地点:第四会议※室A334

                  主持人:陈凌 研究员

                  Biography

                  Prof. Lai's extensive grant-funded research covers three major areas. First, using stem cell technology and gene engineering approaches to prevent or treat autoimmune diseases such as multiple sclerosis (MS). Second, developing gene engineering approaches to enhance anti-tumor immunity and treat cancer. And third, using stem cell technology to model and treat genetic diseases such as DiGeorge Syndrome (DGS). These studies have resulted in the award of two patents and numerous grants with funding exceeding $5 million from the NIH, American Cancer Society, Connecticut Regenerative Medicine Research Fund, and others.

                附件: